We are live on
!
Find out more
Milestone Pharmaceuticals
MIST
MIST
43 hedge funds and large institutions have $43.6M invested in Milestone Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
9% more capital invested
Capital invested by funds: $39.9M → $43.6M (+$3.7M)
8% more funds holding
Funds holding: 40 → 43 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 9
2.83% less ownership
Funds ownership: 56.66% → 53.83% (-2.8%)
Holders
43
Holders Change
+3
Holders Change %
+7.5%
% of All Funds
0.62%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
4
Increased
9
Reduced
9
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$130K |
| 2 |
BCM
BML Capital Management
Zionsville,
Indiana
|
+$48.3K |
| 3 |
PAM
PVG Asset Management
Golden,
Colorado
|
+$44.2K |
| 4 |
Millennium Management
New York
|
+$41.6K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$33.7K |
Top Sellers
| 1 |
LPC
Lion Point Capital
New York
|
-$998K |
| 2 |
ACM
Altium Capital Management
New York
|
-$833K |
| 3 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$348K |
| 4 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$254K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$125K |
